INMUNE BIO INC. Increase (Decrease) in Prepaid Expenses, Other
INMUNE BIO INC. (INMB) reported Increase (Decrease) in Prepaid Expenses, Other of $108.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2024-03-28
- INMUNE BIO INC. increase (decrease) in prepaid expenses, other for fiscal 2023 was $108.00K, a 440.00% increase from fiscal 2022.
- INMUNE BIO INC. increase (decrease) in prepaid expenses, other for fiscal 2022 was $20.00K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|
| 2023-12-31 | $108.00K 10-K · filed 2024-03-28 |
| 2022-12-31 | $20.00K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |